Expanding Global Presence, Village Farms International, Inc. Will Ship Cannabis Products to Israel
Village Farms International, Inc., announced that starting later this month it will increase its global presence by beginning to ship cannabis products to the Israeli medical market.
On January 3rd, 2023, Village Farms International, Inc. announced it will begin to ship cannabis products through its subsidiary, Pure Sunfarms, to Israel’s medical cannabis market as part of an exclusive three-year supply agreement with Dr. Samuelov Importing and Marketing Ltd., doing business as Better Pharma (1).
According to the press release (1), the company also commented that the lack of cannabis legislative action by the United States Senate does not impact Village Farms' plans to leverage its success in Canada into other cannabis markets with greater regulatory support. The company currently sells products in Canada and Australia, and plans to enter the German medical market.
"Commencing shipments to Israel is another milestone in our global cannabis strategy, building on our successes in Canada and Australia," said Michael DeGiglio, Chief Executive Officer, Village Farms (1). "We are proud and privileged to partner exclusively with Better Pharma for the significant medical cannabis opportunity in Israel and are confident that Pure Sunfarms’ unique ‘Everyday Premium’ positioning, which has proven so successful in Canada and Australia, will be differentiated in the Israeli market, and well-received by patients."
"Our agreement with Better Pharma marks the first time Pure Sunfarms branded flower, inclusive of Canada's top-selling Pink Kush, makes its way to consumers internationally," said Mandesh Dosanjh, President and CEO, Pure Sunfarms (1).
"We are proud and honoured to exclusively partner with Pure Sunfarms, Canada's Number 1 flower brand and market leader, for medical cannabis products," said Ran Samuelov, Chief Executive Officer, Better Pharma (1). "We are confident we will be able to leverage our knowledge and expertise in international brand management for Pure Sunfarms to become one of the leading medical cannabis brands in Israel.”
According to information in the press release (1), Better Pharma imports, markets, and distributes international brands to the Israeli pharmaceutical market. In 2020, the company established the Cannabinoids unit, specializing in importing and distribution and marketing of medical grade cannabis product to the Israeli medical market.
Reference
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
The Cost of Compliance in the Cannabis Industry
April 1st 2025The financial and reputational risks of non-compliance far outweigh the upfront investment required to establish robust compliance systems. This blog explores the true cost of compliance, what non-compliance can mean for a business, and why investing in compliance is a proactive, strategic decision rather than a burdensome expense.
